HLA antigens in schizophrenia.
Human leukocyte antigen (HLA) typing was performed on 55 white schizophrenic patients, who were subdivided into groups on the basis of clinical subtype, response to neuroleptic treatment, enlargement of the lateral ventricles, presence of increased prefrontal or parieto-occipital markings, and presence of reversed frontal or occipital lobe asymmetry. No observed differences in antigen frequencies between the group as a whole and controls or between any subgroup and the remaining group or controls remained significant after correction for the number of antigens tested.
Alexander
R C
RC
Neuropsychiatry Branch, National Institute of Mental Health, Washington, DC.
Coggiano
M
M
Daniel
D G
DG
Wyatt
R J
RJ
D004292:Dominance, Cerebral / Q000235:genetics; D005260:Female; D005787:Gene Frequency / Q000235:genetics; D008040:Genetic Linkage / Q000235:genetics*; D015234:HLA-A Antigens / Q000235:genetics*; D015235:HLA-B Antigens / Q000235:genetics*; D006220:Haloperidol / Q000627:therapeutic use; D006801:Humans; D008297:Male; D019965:Neurocognitive Disorders / Q000235:genetics; D011569:Psychiatric Status Rating Scales; D012307:Risk Factors; D012559:Schizophrenia / Q000188:drug therapy / Q000235:genetics*; D012565:Schizophrenic Psychology; D014057:Tomography, X-Ray Computed
D015234:HLA-A Antigens; D015235:HLA-B Antigens; D006220:Haloperidol